Renoxtin Injection 5 mg/ml contains Oxaliplatin, a platinum-based chemotherapeutic agent widely used in the treatment of various cancers, particularly colorectal cancer. Oxaliplatin works by interfering with the DNA of cancer cells, preventing their replication and inducing programmed cell death (apoptosis). Administered intravenously, Renoxtin provides targeted systemic therapy and is typically used as part of combination chemotherapy regimens.

Renoxtin Injection is formulated under strict pharmaceutical standards to ensure potency, sterility, and safety, making it a reliable choice for oncology treatments.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Effective Chemotherapy Agent
  Oxaliplatin is a cornerstone drug in the management of colorectal cancer, including advanced or metastatic cases. It is often combined with 5-fluorouracil (5-FU) and leucovorin in standard regimens such as FOLFOX.

• Targeted Action on Cancer Cells
  Renoxtin forms cross-links within DNA strands, disrupting replication and transcription, which results in cancer cell death while minimizing effects on normal cells when administered properly.

• Enhances Combination Therapy Outcomes
  Studies show that oxaliplatin-based regimens improve survival rates and reduce disease progression when used in combination with other chemotherapeutic agents.

• Intravenous Formulation for Precision
  Being an injectable preparation, Renoxtin allows controlled delivery directly into the bloodstream, ensuring rapid distribution and predictable dosing.

Indications

Renoxtin Injection 5 mg/ml is indicated for:

• Treatment of colorectal cancer, including advanced or metastatic stages

• Use in combination chemotherapy regimens (e.g., FOLFOX)

• Adjuvant therapy following surgical resection of colorectal tumors

• Other cancers as determined by an oncologist based on clinical evidence

Dosage and Administration

• Administration: Intravenous infusion only, as prescribed by a qualified oncologist

• Dosage: Depends on body surface area, type of regimen, and patient tolerance. Typical dosing is calculated in mg/m² and given over a specified infusion period.

• Monitoring: Patients should be monitored for hematologic, hepatic, and renal function before and during therapy. Neuropathy and allergic reactions should be observed closely.

Important: Dosage adjustments may be necessary in patients with kidney or liver impairment. Only trained medical personnel should administer Renoxtin.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions & Safety

• Common Side Effects: Peripheral neuropathy, nausea, vomiting, diarrhea, fatigue, myelosuppression

• Serious Reactions: Allergic reactions, liver toxicity, kidney impairment, severe neutropenia

• Pregnancy and Lactation: Not recommended; consult an oncologist before use

• Drug Interactions: Avoid concurrent use with nephrotoxic drugs or other agents that may exacerbate neuropathy

• Storage: Store below 25°C, protect from light, and do not freeze. Use immediately after preparation or follow recommended storage guidelines for diluted solutions.

Why Choose Renoxtin?

Renoxtin Injection 5 mg/ml provides a reliable, clinically proven option for the treatment of colorectal cancer and other malignancies requiring platinum-based chemotherapy. With strict quality control, precise dosing, and well-studied efficacy, Renoxtin ensures optimal therapeutic outcomes while supporting oncologists in delivering effective combination therapy regimens.